What Sell-Side Advisors Get Wrong About Quality Of Earnings Timing
A founder came to us six weeks after his LOI was signed, in the middle of buyer QoE, with a value compression problem that nobody in the room had seen coming. The compression was real. It was three turns of EBITDA. It was also, on the structural diagnostic we ran in the next forty-eight hours, almost entirely forecastable from characteristics of the business that had been visible to anyone who looked eight months earlier.
The advisor on the deal was competent. The QoE provider on the buyer side was competent. The lawyers on both sides were competent. The thing that broke the transaction was not competence. It was timing.
The technical move I want to write about is the sequencing of the sell-side quality of earnings work relative to the LOI. Most sell-side advisors I see in the lower middle market treat the sell-side QoE as a defensive document. It is built in the period between teaser and management presentations, used to support the management financials package, and then handed to the buyer as part of the diligence opener. The logic is that a buyer-friendly sell-side QoE narrows the buyer's range of questions, shortens the diligence period, and protects against ambush findings in late diligence.
That logic was correct in 2018. It is not correct in early 2026.
The buyer underwriting environment has changed in a way that breaks the sequencing. Buyers in 2026 are running three structurally different underwriting models depending on archetype, and the QoE work they commission tests for different things across those archetypes. A strategic buyer's QoE tests the synergy case the strategic has built into its valuation. A platform private equity buyer's QoE tests recurring revenue density, customer concentration risk, and management depth. A search or independent sponsor's QoE tests free cash flow predictability and the founder transition arc. The same target gets three structurally different QoE workstreams, and the sell-side document that satisfied one archetype is often the document that triggers the most aggressive compression in another.
We published a working paper on the structural pattern this spring, The Buyer Lane Preparation Map (DOI 10.2139/ssrn.6735844). The named finding is that the divergence in indicated value across the three buyer archetypes for the same target is large (median 31 percent of the highest indicated value across the population studied) and forecastable from observable characteristics of the target. The paper documents the underwriting-model divergence. The corollary, which the paper touches on but does not develop, is that the diligence workstream divergence is the operational expression of the underwriting divergence. Different underwriters test for different things in QoE because they are pricing different things.
Three implications for sell-side advisors.
One. The sell-side QoE is not a single document anymore. It is a base document plus archetype-specific annexes. The base document handles the universal questions (revenue recognition, working capital normalization, add-back defensibility, customer cohort analysis). The annexes handle the archetype-specific tests. A strategic-positioned process needs a synergy annex that pre-empts the strategic's synergy QoE. A platform-positioned process needs a recurring revenue and management-depth annex. A search-positioned process needs a cash-flow predictability and transition annex. Building the annexes in advance is cheap. Reverse-engineering them under buyer pressure during diligence is expensive.
Two. The sequencing matters more than the volume. The single highest-leverage move in our data is to commission the sell-side QoE not at the teaser stage but at the buyer-archetype decision stage, which sits roughly twelve to fourteen months before the targeted close. That timing gives the founder a full operating cycle to close the structural gaps the QoE surfaces. The eight-week version, run after marketing has begun, surfaces the gaps too late to close them.
Three. The advisor's job is not just to commission the QoE. It is to translate the QoE findings into the buyer-archetype preparation roadmap. The founders who keep close value in 2026 are the ones whose advisors translated the diagnostic into a preparation work plan eight to twelve months before LOI, and who executed the plan. The founders who lose close value are the ones whose advisors handed them a clean QoE document and moved on to the next stage of the process.
The compression case I opened with had a clean sell-side QoE. The compression came because the QoE was built for a platform PE buyer underwriting model, and the buyer who actually emerged was a strategic with a synergy QoE that tested questions the sell-side document did not anticipate. The structural diagnostic we ran in the post-LOI window surfaced the gap. The repair work was possible but expensive, and three of the gap turns held into close.
The diagnostic was free. It is the same diagnostic our team can run on any business in the window. The advisor who runs it twelve months before LOI is doing the work the advisor in the post-LOI compression window is trying to do under buyer-controlled timing. The first version is cheap. The second version is what produces the founder calls.
Sell-side advisors in the lower middle market have not yet recalibrated for the buyer-archetype divergence the underwriting environment has produced. The advisors who do recalibrate are going to keep the percentage of close value that their clients deserve. The ones who do not are going to keep producing clean defensive sell-side QoE documents that fail to anticipate the question the buyer is actually going to ask.